Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$507.42 USD
+1.08 (0.21%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $507.62 +0.20 (0.04%) 4:32 PM ET
2-Buy of 5 2
D Value C Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$507.42 USD
+1.08 (0.21%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $507.62 +0.20 (0.04%) 4:32 PM ET
2-Buy of 5 2
D Value C Growth B Momentum C VGM
Zacks News
Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $386.37, indicating a -0.49% shift from the previous trading day.
Select Medical (SEM) Q4 Earnings Beat on Patient Admissions
by Zacks Equity Research
Select Medical's (SEM) Q4 results reflect strong segmental contribution, aided by higher patient days and visits. Management expects 2024 adjusted EBITDA to be $830-$880 million, up from the 2023 reported figure of $807.4 million.
Wall Street Bulls Look Optimistic About Intuitive Surgical, Inc. (ISRG): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Intuitive Surgical, Inc. (ISRG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Why Is Intuitive Surgical, Inc. (ISRG) Up 2.8% Since Last Earnings Report?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $380.23, denoting a +0.69% change from the preceding trading day.
Is Trending Stock Intuitive Surgical, Inc. (ISRG) a Buy Now?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
by Zacks Equity Research
Sector ETF report for IHI
Intuitive Surgical (ISRG) Seeks FDA Nod for Next-Gen da Vinci 5
by Zacks Equity Research
Intuitive Surgical (ISRG) aims to boost its da Vinci portfolio with the addition of its next-generation da Vinci 5 multiport surgical robot.
Intuitive Surgical (ISRG) Q4 Earnings Beat, Procedures Robust
by Zacks Equity Research
Intuitive Surgical's (ISRG) fourth-quarter results reflect healthy demand for procedures, partially offset by lower system sales. Higher pricing boosts procedure sales.
Zacks Investment Ideas feature highlights: Intuitive Surgical
by Zacks Equity Research
Intuitive Surgical have been highlighted in this Investment Ideas article.
Medical Instrument Provider Eyes Breakout Amid Upbeat Earnings Results
by Bryan Hayes
Improving procedure volumes and solid recurring revenue are key catalysts.
Here's What Key Metrics Tell Us About Intuitive Surgical, Inc. (ISRG) Q4 Earnings
by Zacks Equity Research
The headline numbers for Intuitive Surgical, Inc. (ISRG) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
S&P Hits New All-Time High; Netflix, T.I. Mixed in Q4
by Mark Vickery
NFLX's net subscriber adds blew the doors off expectations: 13 million versus 8.9 million estimated.
5 Red Hot Stocks with Fabulous Earnings Records
by Tracey Ryniec
All 5 of these stocks are coming off of an earnings beat last quarter.
Is a Beat Likely for Intuitive Surgical (ISRG) in Q4 Earnings?
by Zacks Equity Research
Intuitive Surgical's (ISRG) fourth-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.
Intuitive Surgical, Inc. (ISRG) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) closed the most recent trading day at $374.82, moving +0.78% from the previous trading session.
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Intuitive Surgical, Inc. (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
What Analyst Projections for Key Metrics Reveal About Intuitive Surgical, Inc. (ISRG) Q4 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of Intuitive Surgical, Inc. (ISRG) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to raise optimism among investors, owing to its strength in robotics.
Intuitive Surgical, Inc. (ISRG) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) reachead $362.33 at the closing of the latest trading day, reflecting a -0.38% change compared to its last close.
Intuitive Surgical, Inc. (ISRG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should You Buy Intuitive Surgical (ISRG) Ahead of Earnings?
by Zacks Equity Research
Intuitive Surgical (ISRG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The Zacks Analyst Blog Highlights Advanced Micro Devices, Abbott Laboratories, Qualcomm, Morgan Stanley and Intuitive Surgical
by Zacks Equity Research
Advanced Micro Devices, Abbott Laboratories, Qualcomm, Morgan Stanley and Intuitive Surgical are included in this Analyst Blog.